G Tardif
Overview
Explore the profile of G Tardif including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martel-Pelletier J, Tardif G, Rousseau Trepanier J, Abram F, Dorais M, Raynauld J, et al.
Osteoarthritis Cartilage
. 2019 May;
27(8):1163-1173.
PMID: 31102776
Objective: There is a need to identify reliable biomarkers that can predict knee osteoarthritis (OA) progression. We investigated a panel of adipokines and some related inflammatory factors alone and their...
2.
Gouarne C, Tracz J, Paoli M, DeLuca V, Seimandi M, Tardif G, et al.
Br J Pharmacol
. 2014 Sep;
172(1):235-45.
PMID: 25220617
Background And Purpose: Parkinson's disease (PD) is usually diagnosed clinically from classical motor symptoms, while definitive diagnosis is made postmortem, based on the presence of Lewy bodies and nigral neuron...
3.
Tardif G, Pelletier J, Boileau C, Martel-Pelletier J
Osteoarthritis Cartilage
. 2008 Aug;
17(2):263-70.
PMID: 18691909
Objective: Bone morphogenic protein (BMP) activities are controlled in part by antagonists. In human osteoarthritic (OA) cartilage, the BMP antagonists follistatin and gremlin are increased but differentially regulated. Using the...
4.
Fan Z, Tardif G, Hum D, Duval N, Pelletier J, Martel-Pelletier J
Ann Rheum Dis
. 2008 Jul;
68(6):976-82.
PMID: 18593760
Background: Human osteoarthritic (OA) chondrocytes were previously classified into L (low)- and H (high)-OA according to matrix metalloproteinase-13 (MMP-13) basal levels and interleukin 1beta (IL1beta) inducibility. In H-OA chondrocytes, the...
5.
Monfort J, Tardif G, Roughley P, Reboul P, Boileau C, Bishop P, et al.
Osteoarthritis Cartilage
. 2008 Jan;
16(7):749-55.
PMID: 18164633
Objective: One of the proteoglycan families is the small leucine-rich proteoglycans (SLRPs) that are characterized by their association with collagen fibrils and/or some glycosaminoglycans. Opticin is a glycoprotein and class...
6.
Marshall S, Tardif G, Ashworth N
Cochrane Database Syst Rev
. 2007 Apr;
(2):CD001554.
PMID: 17443508
Background: Carpal tunnel syndrome is a clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the carpal tunnel in the wrist. Local corticosteroid injection for...
7.
Tardif G, Pelletier J, Hum D, Boileau C, Duval N, Martel-Pelletier J
Ann Rheum Dis
. 2006 Jan;
65(2):261-4.
PMID: 16410531
Objective: To investigate the distribution of the bone morphogenic protein (BMP) antagonist chordin in normal and osteoarthritic cartilage and synovial membranes, and its regulation in chondrocytes and synovial fibroblasts by...
8.
Boileau C, Pelletier J, Tardif G, Fahmi H, Laufer S, Lavigne M, et al.
Ann Rheum Dis
. 2004 Oct;
64(6):891-8.
PMID: 15498796
Background: MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual inhibitor of cyclo-oxygenases (COX) and 5-lipoxygenase (5-LOX), can modulate MMP-13 production in human...
9.
Tardif G, Dupuis M, Reboul P, Geng C, Pelletier J, Ranger P, et al.
Osteoarthritis Cartilage
. 2003 Jun;
11(7):524-37.
PMID: 12814616
Objective: Collagenase-3 is a metalloprotease that plays a role in tissue remodeling and pathological processes including arthritis. The human gene is transcribed into major (3.0 and 2.5 kb) and minor...
10.
Marshall S, Tardif G, Ashworth N
Cochrane Database Syst Rev
. 2003 Jan;
(4):CD001554.
PMID: 12519560
Background: Carpal tunnel syndrome is a clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the level of the carpal tunnel in the wrist. Local...